Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PHARMX TECHNOLOGIES LIMITED Legal Proceedings Report 2021

Dec 6, 2021

65560_rns_2021-12-06_38918250-226e-4560-b02a-7233cfb15f6e.pdf

Legal Proceedings Report

Open in viewer

Opens in your device viewer

Corum Group Limited ABN 25 000 091 305 Level 3, 120 Sussex Street, Sydney NSW 2000 www.corumgroup.com.au

==> picture [157 x 72] intentionally omitted <==

Market Release

7 December 2021

ASX Announcement

Update on Legal Proceedings relating to PharmX

Corum Group Limited ( Corum ) (ASX:COO) provides the following update on legal proceedings relating to group member PharmX Pty Ltd ( PharmX ). PharmX is a wholly owned subsidiary of Corum Systems Pty Ltd ( Corum Systems ), which is a wholly owned subsidiary of Corum.

On 14 May 2021, Corum reported on legal proceedings commenced by Corum Systems against Fred IT Group Pty Ltd ( Fred ). In those proceedings, Corum Systems claims that:

  1. following the change of control of Fred in 2013, Fred continued to receive a share of the distributions from PharmX for the FY14-FY19 years to which Fred was not entitled; and

  2. the price payable to acquire Fred’s PharmX securities should have been the lower price calculated by reference to the 2013 change of control, rather than as at the 2020 acquisition.

Fred is defending those proceedings.

On 14 May 2021, Corum also reported on legal proceedings commenced by Fred against PharmX, in which Fred claims that it is entitled to a share of the distributions from PharmX for the FY20 year. Fred ceased to be a securityholder in PharmX part way through that year. PharmX considers that Fred’s claims in these proceedings are very weak, and is defending the proceedings.

Pursuant to Orders that have now been made in the Victorian Supreme Court, evidence in both proceedings (which are travelling together) will be served by the parties in the first half of 2022, and the proceedings are then listed for hearing for 7 days commencing on 24 October 2022.

- ENDS -

This notice has been authorised for release to the ASX by the Board of the Company.

For further information please contact: Nick England, Chairman [email protected]

==> picture [596 x 66] intentionally omitted <==

----- Start of picture text ----- Corum Group | Corum Health | Corum eCommerce | PharmXSydney | Melbourne | Perth | Brisbane | Adelaide corumgroup.com.au----- End of picture text -----

About Corum Group

Corum Group Limited [ASX:COO] (Corum) is an Australian company limited by shares that owns businesses in technology and software development.

For more than 30 years Corum has been using its deep industry expertise and extensive relationships to develop Point-Of-Sale, Dispensing and Management software for pharmacy head offices and retail stores and a range of eCommerce and ordering solutions throughout Australia. Corum Health now also includes PharmX, an electronic gateway that links pharmacies, pharmaceutical wholesalers and direct suppliers within the pharmacy market.

Corum is determined to offer the best solutions to its customers through the products, services and processes of each of its businesses.

==> picture [596 x 66] intentionally omitted <==

----- Start of picture text ----- Corum Group | Corum Health | Corum eCommerce | PharmXSydney | Melbourne | Perth | Brisbane | Adelaide corumgroup.com.au----- End of picture text -----